Skip to main content

FDA 預測與賠率

·
FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

15%

$569K 交易量

$4.7K Liq.

3

Ends 7 個月內

FDA approves Ionis' Olezarsen?

FDA approves Ionis' Olezarsen?

73%

$957 交易量

$1.7K Liq.

Ends 22 天內

FDA approves GSK & Spero Therapeutics' Tebipenem HBr?

FDA approves GSK & Spero Therapeutics' Tebipenem HBr?

70%

$3.3K 交易量

$2.1K Liq.

Ends 10 天內

FDA approves Arcutis' Zoryve cream?

FDA approves Arcutis' Zoryve cream?

70%

$732 交易量

$1.8K Liq.

Ends 21 天內

Who will Trump announce as next FDA commissioner?

Who will Trump announce as next FDA commissioner?

40%

Kyle Diamantas

$11.6K 交易量

$20.8K Liq.

Ends 7 個月內

FDA approves Arcalyst technology transfer?

FDA approves Arcalyst technology transfer?

81%

$2.1K 交易量

$1.7K Liq.

Ends 11 天內

FDA approves Viridian Therapeutics' Veligrotug?

FDA approves Viridian Therapeutics' Veligrotug?

72%

$2.1K 交易量

$2.0K Liq.

Ends 22 天內

FDA approves Unicycive's Oxylanthanum carbonate?

FDA approves Unicycive's Oxylanthanum carbonate?

72%

$3.1K 交易量

$1.5K Liq.

Ends 21 天內

FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?

FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?

79%

$208 交易量

$410 Liq.

Ends 11 天內

FDA approves Camurus' Oclaiz?

FDA approves Camurus' Oclaiz?

75%

$347 交易量

$314 Liq.

Ends 2 天內

FDA approves Daraxonrasib this year?

FDA approves Daraxonrasib this year?

75%

$66 交易量

$1.7K Liq.

Ends 7 個月內

Hantavirus vaccine in 2026?

Hantavirus vaccine in 2026?

7%

$118K 交易量

$36.3K Liq.

7

Ends 7 個月內

Weed rescheduled by...?

Weed rescheduled by...?

32%

December 31

$762K 交易量

$25.8K Liq.

Ends 2 個月前

Hyperliquid airdrop by ....?

Hyperliquid airdrop by ....?

46%

December 31, 2027

$495K 交易量

$4.7K Liq.

31

Ends 超過 1 年內

SCOTUS lets Trump fire FTC commissioners in Trump v. Slaughter?

SCOTUS lets Trump fire FTC commissioners in Trump v. Slaughter?

92%

$21.8K 交易量

$16.4K Liq.

1

Ends 7 個月內

Measles cases in U.S. in 2026?

Measles cases in U.S. in 2026?

83%

↑3k

$8M 交易量

$23.1K Liq.

Ends 7 個月內

Fed decisions (Mar-Jun)

Fed decisions (Mar-Jun)

99%

Pause–Pause–Pause

$2M 交易量

$55.4K today

$103K Liq.

Ends 9 天內

MegaETH airdrop by...?

MegaETH airdrop by...?

34%

December 31, 2026

$3M 交易量

$8.3K Liq.

135

Ends 7 個月內

US grants license for new nuclear reactor in 2026?

US grants license for new nuclear reactor in 2026?

22%

$23.6K 交易量

$1.1K Liq.

2

Ends 7 個月內

Jerome Powell out of Fed Board by…?

Jerome Powell out of Fed Board by…?

39%

December 31

$418K 交易量

$5.7K Liq.

22

Ends 7 個月內

Frequently Asked Questions

Polymarket is the world’s largest prediction market, where you can stay informed and profit from your knowledge by trading on things related to breaking news, politics, sports, elections, crypto, finance, tech, culture, including topics like FDA.

Polymarket currently hosts 112 active markets for FDA that lets you track or trade on predictions like “FDA approves Retatrutide this year?”. Whether you are tracking widely debated events or niche outcomes, the platform aggregates real-time odds based on over $14.2M in trading volume, providing a comprehensive view of fan and investor sentiment.

Each polymarket is a yes/no question, like “Hantavirus vaccine in 2026? ”. You buy shares in “yes” or “no” outcomes. Prices reflect crowd-sourced odds and probabilities. For example, if yes is at 30 cents, that’s a 30% chance. Markets resolve based on official results. For multi-outcome events, like “Measles cases in U.S. in 2026?,” you simply trade on the specific outcome you think will win.

As of today, the most active market is “Measles cases in U.S. in 2026?,” where the crowd is currently assigning a 83% chance to ↑3k. These odds update in real-time as new information emerges and users trade, offering a dynamic snapshot of what the market believes will happen compared to traditional bookmaker odds.

It cuts through the noise. Unlike polls or punditry, Polymarket shows you real-time odds on FDA predictions backed by financial conviction that are often faster and more accurate than experts or surveys. You get an unbiased view of what thousands of traders think will actually happen, often more accurate than polls. Plus, you can trade shares and potentially profit if your predictions are spot on.